GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Equity-to-Asset

CellSource Co (TSE:4880) Equity-to-Asset : 0.89 (As of Apr. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. CellSource Co's Total Stockholders Equity for the quarter that ended in Apr. 2024 was 円6,097 Mil. CellSource Co's Total Assets for the quarter that ended in Apr. 2024 was 円6,876 Mil. Therefore, CellSource Co's Equity to Asset Ratio for the quarter that ended in Apr. 2024 was 0.89.

The historical rank and industry rank for CellSource Co's Equity-to-Asset or its related term are showing as below:

TSE:4880' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.58   Med: 0.87   Max: 0.91
Current: 0.89

During the past 7 years, the highest Equity to Asset Ratio of CellSource Co was 0.91. The lowest was 0.58. And the median was 0.87.

TSE:4880's Equity-to-Asset is ranked better than
82.67% of 1512 companies
in the Biotechnology industry
Industry Median: 0.67 vs TSE:4880: 0.89

CellSource Co Equity-to-Asset Historical Data

The historical data trend for CellSource Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Equity-to-Asset Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Equity-to-Asset
Get a 7-Day Free Trial 0.87 0.87 0.81 0.82 0.90

CellSource Co Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.89 0.90 0.88 0.89

Competitive Comparison of CellSource Co's Equity-to-Asset

For the Biotechnology subindustry, CellSource Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where CellSource Co's Equity-to-Asset falls into.



CellSource Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

CellSource Co's Equity to Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

Equity to Asset (A: Oct. 2023 )=Total Stockholders Equity/Total Assets
=6201.997/6879.736
=0.90

CellSource Co's Equity to Asset Ratio for the quarter that ended in Apr. 2024 is calculated as

Equity to Asset (Q: Apr. 2024 )=Total Stockholders Equity/Total Assets
=6096.727/6876.231
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


CellSource Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of CellSource Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co Headlines

No Headlines